Latest Research
Page 2 of 76
Unusual Call Buy in COVID Prevention Play
Invivyd (IVVD) unusual large buyers for 7500 Sept $7.50 calls here at $1.10 up to $1.70 as IV spikes higher. Stock has been ramping higher since…
Tags: IVVD
February 8, 2024
Digital Ocean Sets Up Bullish
Digital Ocean (DOCN) strong candle off its rising 55-MA test and a coiled multi-week consolidation while 6450 January 2026 $50 calls have been bought, potential explosive…
Tags: DOCN
February 7, 2024
Unusual Bull Positions in Small Biotech into Q1 Catalyst
Marinus Pharma (MRNS) is a small cap biotech that has seen bullish positions open in July expiration with 1570 July $15 calls opening on 12/26…
Tags: MRNS
February 4, 2024
Large Bull Plays Small Biotech as Potential Next M&A Target
MoonLake (MLTX) shares coiled tightly as a strong Biotech seeing 2K Feb. $65 calls adjust to March $65 that open $5.94 while 1250 of the…
Tags: MLTX
January 30, 2024
Highly Unusual Upside Call Spread in Small Biotech with Key Data
Astria Therapeutic (ATXS) massive unusual buy of 10,000 April $10/$15 call spreads with shares up 13% today clearing the 200-MA and consolidation flag. The $350M…
Tags: ATXS
January 25, 2024
Unusual Call Buys Sees Upside in Small Biotech
MacroGenics (MGNX) unusual 975 June $15 calls bought $1.35, strong trend chart in Biotech. Citi upgraded to Buy 12/9 noting continued execution across the pipeline,…
Tags: MGNX
January 16, 2024
Bulls Position for Key Catalyst in Breast Implant Leader
Establishment Labs (ESTA) another 1000 February $50/$70 call spreads bought, keeps seeing upside call spreads into this ugly sell-off. JPM started Overweight with $75 target…
Tags: ESTA
October 5, 2023
Call Buys into Large Biotech Leader Weakness
Agenyx (ARGX) spiked off morning lows as 500 December $540 calls bought to open $14.40 to $18 aggressively into weakness. ARGX is testing and holding…
Tags: ARGX
September 26, 2023
Unusual Put Sale Bull Signal in Rocket Pharma
Rocket Pharma (RCKT) opening seller 2000 January $20 puts $2.40 with stock at $20.70, very bullish signal in smaller Bio that dipped to 8-MA after recent…
Tags: RCKT
September 22, 2023
NASH Small Cap Biotech Sees Bullish Options Open Interest Swell
Akero Therapeutic (AKRO) into weakness on 6/26 with 1000 January $55 calls bought $6.10 to $6.90 and follows recent opening sales of 9800 August $50…
Tags: AKRO
June 27, 2023
Page 2 of 76